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Introduction: Extramammary Paget’s disease is a rare histological type of intraepithelial adenocarcinoma that
mainly affects apocrine sweat gland-rich areas. Predilection sites include the anogenital region and, less commonly,
the axillae. These tumors rarely occur in non-apocrine regions. The aim of this case report is to describe a case of
extramammary Paget’s disease in the external auditory canal with extensive temporal bone involvement and skull
base invasion.
Case presentation: A 40-year-old Caucasian man presented with a progressively growing, vegetating lesion
localized in his right-hand external auditory canal. He had peripheral facial nerve paralysis and complete ipsilateral
hearing loss. An incisional biopsy suggested extramammary Paget’s disease, and the immunohistochemical analysis
confirmed the diagnosis. The tumor was considered inoperable because of the extensive skull base involvement,
and he was referred for palliative radiotherapy.
Conclusion: We report here the third case of extramammary Paget’s disease affecting the external auditory canal to be
described in the literature. In all the three cases, the prognosis was unfavorable despite treatment.
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Extramammary Paget’s disease (EMPD) is a rare histo-
logical type of intraepithelial adenocarcinoma that
mainly affects apocrine sweat gland-rich areas. The pre-
dilection sites include the anogenital region and, less
commonly, the axillae [1]. These tumors rarely occur in
non-apocrine regions. Despite the presence of modified
ceruminous sweat glands in the external auditory canal,
there have been only two previously reported cases of
EMPD in this region [2,3]. The aim of this case report is
to describe the case of a patient with EMPD in the
external auditory canal, with extensive temporal bone in-
volvement and skull base invasion. The patient had a
good initial response to radiotherapy but developed a
lung metastasis and died 4 months after the end of
treatment.* Correspondence: walbermendesmed@hotmail.com
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The patient was a 40-year-old Caucasian man who
presented with a 3-month history of a progressively
growing, vegetating lesion localized in his right-hand
external auditory canal. Upon physical examination, a
2.5cm bleeding, ulcerated lesion was observed to oc-
clude his right external auditory canal (Figure 1). The
patient had already developed peripheral facial nerve
paralysis and complete ipsilateral hearing loss.
The incisional biopsy suggested EMPD (Figure 2a,
b), but there was a possible differential diagnosis of
amelanotic melanoma or pagetoid Bowen’s disease.
The immunohistochemical study (Table 1) was positive
for human epidermal growth factor receptor 2 (Her2
or Neu; Figure 2c), carcinoembryonic antigen (CEA;
Figure 2d), cytokeratin-7 (CK7; Figure 2e), and gross
cystic disease fluid protein of 15kDa (GCDFP-15;
Figure 2f ), confirming the diagnosis of EMPD. A com-
puted tomography scan revealed an infiltrative lesion
in his external right ear, with paravertebral and middle
ear extensions that affected his internal carotid artery
anterior wall and facial nerve, respectively (Figure 3a).l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Clinical features of the patient with extramammary
Paget’s disease.
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tumor with imprecise limits and no cleavage plane with
the carotid artery. An extension to the parapharyngeal
space and an invasion of the middle fossa, associated
with meningeal contrast enhancement, were observed
(Figure 3b).
The tumor was considered inoperable because of the
extensive skull base involvement, and the patient wasFigure 2 Histopathological examination and immunohistochemical st
largely concentrated in the deep epidermis. Epidermal hyperplasia and hyp
original magnification ×40). (b) The tumor cells were large, with distinct bo
nucleoli (hematoxylin and eosin staining, original magnification ×200). (c) St
reactivity was detected in Paget’s cells in the epidermis (original magnif
carcinoembryonic antigen (original magnification ×400). (e) Extramammary Pa
infiltration (original magnification ×40). (f) Reactivity for gross cystic disease flureferred for palliative radiotherapy. The patient under-
went 36 sessions of radiotherapy and was given a total
radiation dose of 72Gy. A complete response was
achieved at the primary site, but during treatment, dif-
fuse bilateral pulmonary metastases were detected. The
patient experienced significant weight loss during treat-
ment and died 4 months after completing radiotherapy.
Discussion
EMPD was first reported by Crocker in 1889 [4] and is a
rare type of adenocarcinoma of the apocrine sweat
glands with intraepithelial extension [1] that primarily
affects sites with high densities of these glands, such as
the genital, perianal, and axillary regions [5]. Other sites
are quite rarely affected; these include the external audi-
tory canal [2,3], upper eyelid (glands of Moll) [6], and
umbilical region [7], where there is evidence of modified
apocrine glands. In addition, EMPD can occur in places
with no evidence of apocrine glands, such as the face
[8]. In such cases, EMPD is described as ectopic.
In its usual presentation in the genital and perianal re-
gions, EMPD is reported as a slow-growing, erythema-
tous, and well-demarcated lesion that forms crusts, scaly
edges, and occasional ulcerations. These tumors grow
until achieving local invasion and metastasis [9]. Precise
diagnoses are often delayed for years due to nonspecific
appearances [10]. The behaviors of EMPD that have
been described in the literature are very different fromudy. Detailed legend: (a) An extensive infiltrate with involvement
erkeratosis occurred to some degree (hematoxylin and eosin staining,
rders, abundant pale cytoplasm, pleomorphic nuclei, and conspicuous
rong human epidermal growth factor receptor 2-positive membranous
ication ×200). (d) Paget’s cells showing diffuse positivity for
get’s disease manifested as cytokeratin-positive malignant cell epidermal
id protein of 15kDa (original magnification ×200).
Table 1 Immunohistochemical analysis
Antibody Antibody dilution Result
p63 1/300 Negative




Cerb-B2 1/1500 Positive (+++)
CEA mono 1/200 Focally positive (++)
CEA poly 1/2000 Positive (+++)
GCDFP-15 1/50 Positive (++)
Abbreviations: CEA mono carcinoembryonic antigen monoclonal antibody, CEA
poly CEA polyclonal antibody, CK7 cytokeratin-7, GCDFP-15 gross cystic disease
fluid protein of 15kDa, HMB-45 human melanoma black-45, Melan-A
melanoma antigen.
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presented with rapid and aggressive growth, including
lymph node metastasis within a few months, and led to
the patient’s death.
Cases of EMPD that affect the external auditory canal
are extremely rare. Such a case was first published by
Kaneko and Fligiel [3] in 1975 and then by Gonzalez-
Castro et al. [2] in 1998. In both cases, EMPD was very
aggressive, and the patients died within months of the
diagnoses, despite treatment. The case described here is
the third reported case. Adenocarcinomas that arise
from the ceruminous glands of the external auditory
canal are rare malignancies that usually present as grow-
ing and painful masses in the external auditory canals of
middle-aged patients [11]. Besides ear pain and rapid
tumor growth, the most common symptoms include
hearing impairments such as hearing loss, deafness and
tinnitus, discharge, infection, bleeding, facial nerve par-
alysis, paresthesia, dizziness, and balance disorders [12].Figure 3 Computed tomography and magnetic resonance
imaging. Detailed legend: Computed tomography axial image (a)
and magnetic resonance imaging coronal image (b) of the head,
performed without (a) and with (b) the administration of contrast
material, showing the infiltrative lesion in the external right ear and
its relation to anatomical structures.Immunohistochemistry is critical for diagnosis because
the histological aspect can resemble amelanotic melan-
oma or pagetoid Bowen’s disease [8]. Markers such as
CEA and low-molecular-weight cytokeratins, including
PKK1, CK7, GR53, and 35 Beta H11, are often positive
in Paget’s cells and apocrine sweat glands [13]. In 2009,
Plaza et al. [14] published a study on a series of 47 pa-
tients with EMPD, in which more than 30% expressed
the Her2 (Neu) receptor. These cases were associated
with potentially more aggressive lesions and had higher
rates of recurrence after treatment. The patient in the
present case had tumor cells positive for CEA, CK7,
Her2 (Neu), and GCDFP-15.
Combined surgical resection and adjuvant radiother-
apy provides the most effective treatment [1]; however,
several series showed good results with radiotherapy
alone in inoperable cases [8]. For metastatic EMPD, most
authors have recommended combinations of multiple
chemotherapy drugs such as 5-fluorouracil, mitomycin C,
vincristine, cisplatin, and epirubicin in combination with
radiotherapy [15]. However, the serious adverse effects of
these treatment regimens should be taken into account
[13]. The detection of Her2 (Neu) in a subgroup of pa-
tients with EMPD could provide a new starting point for
immunotherapy in a manner similar to therapy for Her2
(Neu)-positive breast cancer patients [13,14].
The prognosis of EMPD in its usual presentation is
generally favorable and depends on the extent of the le-
sion, depth of invasion, and lymph node spread [10].
The associated mortality rate ranges from 13% to 18%
[13], and the survival rate at 5 years is 72% [10].Conclusions
In summary, EMPD very rarely affects the external audi-
tory canal, and only two cases have been previously de-
scribed in the literature. In this case and the two
previous cases, the prognosis was unfavorable despite
treatment. If the patient had sought medical attention
earlier, the disease could possibly have been diagnosed at
an initial stage and treated with radical surgery com-
bined with adjuvant radiotherapy and could possibly
have been healed.Consent
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